Erratum: Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2022.1111059/full |
_version_ | 1811184549960351744 |
---|---|
author | Frontiers Production Office |
author_facet | Frontiers Production Office |
author_sort | Frontiers Production Office |
collection | DOAJ |
first_indexed | 2024-04-11T13:14:11Z |
format | Article |
id | doaj.art-e2f00bac327f45238d1bc1c9b2ee6cd7 |
institution | Directory Open Access Journal |
issn | 1664-042X |
language | English |
last_indexed | 2024-04-11T13:14:11Z |
publishDate | 2022-12-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Physiology |
spelling | doaj.art-e2f00bac327f45238d1bc1c9b2ee6cd72022-12-22T04:22:27ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2022-12-011310.3389/fphys.2022.11110591111059Erratum: Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies Frontiers Production Officehttps://www.frontiersin.org/articles/10.3389/fphys.2022.1111059/fullmyosinhypertrophic cardiomyopathysuper relaxed statemavacamtenomecamtiv mercarbil |
spellingShingle | Frontiers Production Office Erratum: Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies Frontiers in Physiology myosin hypertrophic cardiomyopathy super relaxed state mavacamten omecamtiv mercarbil |
title | Erratum: Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies |
title_full | Erratum: Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies |
title_fullStr | Erratum: Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies |
title_full_unstemmed | Erratum: Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies |
title_short | Erratum: Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies |
title_sort | erratum hypertrophic cardiomyopathy mutations to mechanisms to therapies |
topic | myosin hypertrophic cardiomyopathy super relaxed state mavacamten omecamtiv mercarbil |
url | https://www.frontiersin.org/articles/10.3389/fphys.2022.1111059/full |
work_keys_str_mv | AT frontiersproductionoffice erratumhypertrophiccardiomyopathymutationstomechanismstotherapies |